Our product suite of technologies target the following bio-terrorism industry segments:
While these germs may originally come from nature, the possibility exists to modify or reengineer these pathogens to increase their ability to spread among populations, cause diseases, and/or resist medical treatment.
THE NEED FOR BIO-TERRORISM COUNTERMEASURES & DEFENSE
Biological agents are known to be able to spread through either air, water, and/or in food. Others can spread through personal contact, making detection difficult.
Government and military preparedness for and response to an attack involving such a biological agent are complicated by the sheer number and similarity of many of these agents. Long incubation periods and consequent delayed onset of diseases as well as secondary transmission are all to be considered. Naturally occurring pathogens such as anthrax, ebola, plague, or smallpox (to name a few) used by bioterrorists may be genetically engineered to resist existing treatment and therapies and may evade vaccine-induced immunity.
MARKET GROWTH
EMERGING DISEASES
YEARLY BURDEN
THE COVID-19 COST
Bioterrorism Defense & Harmful Bioagents Countermeasures - The Challenge
There are currently around 1,500 microbes identified to be a known source of disease among the human population. Infectious diseases have contributed to major challenges to human progress and survival along with wars and famine. Confronted with a constant background of new and established infections, epidemics (both new and old) are expected to periodically emerge – grossly impacting the global burden of infections.
Bioterrorism defense can never fully anticipate all eventualities, ranging from defense systems being inept at predicting the most likely scenario. Governing bodies may see higher prioritization for Missile Defense Shields against rogue states over random acts of calculated biological warfare from a hidden and insidious enemy. The challenge in proper preparedness and bio-terrorism defense is multi-faceted, and one such facet is in sterilization and disinfection technologies.
Global Death Burden Of Infectious Diseases
- Respiratory Infections
- HIV & AIDS
- Other Infectious Diseases
- Diarrhoeal Diseases
- Tuberculosis
- Vaccine Preventable Childhood Diseases
- Malaria
- STDS (Other than HIV)
- Meningitis
- Hepatitis B & C
- Tropical Parasitic Diseases
- Dengue Fever
The above listed figure does not include the additional millions of deaths occurring due to past infections (example: Streptococcal Rheumatic Heart Disease) or due to complications correlated with infections that are considered chronic – such as liver failure and hepatocellular carcinoma from persons infected with Hepatitis B or C.
The burden of morbidity (ill health) and mortality associated with infectious diseases falls most heavily on people in developing countries, and particularly on infants and children (about three million children die each year from malaria and diarrhoeal diseases alone). In developed nations, infectious disease mortality disproportionately affects indigenous and disadvantaged minorities. [NCBI] – Figures Published: W.H.O
CONVENTIONAL SOLUTIONS FALL SHORT
Conventional disinfection technologies can only achieve 2-3 logs (99% – 99.9%) of reduction (kill) of pathogens and many fall short for both soft and hard surfaces. Decontamination in this range allows the regrowth of pathogens within as little as 12 hours.
INTRODUCING THE NEW GOLD STANDARD
The Aerimos Disinfectant sprayer prevents regrowth with its industry-disruptive 5 log+ (99.999%+) elimination of all viral & bacterial pathogens, all while leaving zero residue.
